Steven McCune
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- CAR-T cell therapy research
-
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 6
- Lung Cancer Research Studies 3
- Cancer Treatment and Pharmacology 2
-
- Advanced Breast Cancer Therapies 5
- Prostate Cancer Treatment and Research 2
- Co-authors
- Tim M. Townes (4 shared papers)Tarek Mekhail (2 shared papers)Marcin Kowanetz (2 shared papers)Federico Cappuzzo (2 shared papers)Alan Sandler (2 shared papers)Hans‐Georg Kopp (2 shared papers)Alona Zer (2 shared papers)Davey B. Daniel (2 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Cancer Research (3 papers)JAMA (1 paper)Clinical Cancer Research (1 paper)The Oncologist (1 paper)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Steven McCune
19 papers receiving 1.6k citations
Steven McCune's Hit Papers
Peers
Comparison fields: 5 of 77
- Oncology 921
- Pulmonary and Respiratory Medicine 476
- Genetics 100
- Immunology 203
- Genetics 150
Countries citing papers authored by Steven McCune
This map shows the geographic impact of Steven McCune's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven McCune with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven McCune more than expected).
Fields of papers citing papers by Steven McCune
This network shows the impact of papers produced by Steven McCune. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven McCune. The network helps show where Steven McCune may publish in the future.
Co-authors
The 25 scholars most cited alongside Steven McCune, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial Hit paper breakdown → | 2019 | 1183 |
| 2 | 1997 | 227 | |
| 3 | 2004 | 57 | |
| 4 | 1994 | 31 | |
| 5 | 2002 | 31 | |
| 6 | 2021 | 25 | |
| 7 | 2021 | 23 | |
| 8 | 2023 | 18 | |
| 9 | 2001 | 11 | |
| 10 | 2021 | 10 | |
| 11 | 1994 | 9 | |
| 12 | 2019 | 3 | |
| 13 | 2022 | 2 | |
| 14 | 2023 | 2 | |
| 15 | 2019 | 2 | |
| 16 | 2024 | 2 | |
| 17 | 2022 | 1 | |
| 18 | 2022 | 1 | |
| 19 | 2018 | 1 |
About Steven McCune
Steven McCune is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Genetics and Genetics, having authored 19 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Advanced Breast Cancer Therapies (5 papers), Lung Cancer Research Studies (3 papers), CRISPR and Genetic Engineering (3 papers), Prostate Cancer Treatment and Research (2 papers), Animal Genetics and Reproduction (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Oncology (921 citations), Pulmonary and Respiratory Medicine (476 citations), Genetics (100 citations), Immunology (203 citations) and Genetics (150 citations). Steven McCune has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Tim M. Townes, Tarek Mekhail, Marcin Kowanetz, Federico Cappuzzo, Alan Sandler, Hans‐Georg Kopp, Alona Zer, Davey B. Daniel, Niels Reinmuth and Howard West. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, JAMA, Clinical Cancer Research and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.